231 related articles for article (PubMed ID: 30976000)
1. Conformational dynamics of the human serotonin transporter during substrate and drug binding.
Möller IR; Slivacka M; Nielsen AK; Rasmussen SGF; Gether U; Loland CJ; Rand KD
Nat Commun; 2019 Apr; 10(1):1687. PubMed ID: 30976000
[TBL] [Abstract][Full Text] [Related]
2. Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations.
Gabrielsen M; Ravna AW; Kristiansen K; Sylte I
J Mol Model; 2012 Mar; 18(3):1073-85. PubMed ID: 21670993
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.
Coleman JA; Yang D; Zhao Z; Wen PC; Yoshioka C; Tajkhorshid E; Gouaux E
Nature; 2019 May; 569(7754):141-145. PubMed ID: 31019304
[TBL] [Abstract][Full Text] [Related]
4. X-ray structures and mechanism of the human serotonin transporter.
Coleman JA; Green EM; Gouaux E
Nature; 2016 Apr; 532(7599):334-9. PubMed ID: 27049939
[TBL] [Abstract][Full Text] [Related]
5. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine.
Field JR; Henry LK; Blakely RD
J Biol Chem; 2010 Apr; 285(15):11270-80. PubMed ID: 20159976
[TBL] [Abstract][Full Text] [Related]
7. Occlusion of the human serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain.
Gradisch R; Szöllősi D; Niello M; Lazzarin E; Sitte HH; Stockner T
J Biol Chem; 2022 Mar; 298(3):101613. PubMed ID: 35065961
[TBL] [Abstract][Full Text] [Related]
8. Identification of the potassium-binding site in serotonin transporter.
Hellsberg E; Boytsov D; Chen Q; Niello M; Freissmuth M; Rudnick G; Zhang YW; Sandtner W; Forrest LR
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2319384121. PubMed ID: 38652746
[TBL] [Abstract][Full Text] [Related]
9. Computational approaches for the study of serotonin and its membrane transporter SERT: implications for drug design in neurological sciences.
Pratuangdejkul J; Schneider B; Launay JM; Kellermann O; Manivet P
Curr Med Chem; 2008; 15(30):3214-27. PubMed ID: 19075665
[TBL] [Abstract][Full Text] [Related]
10. Electrogenic Binding of Intracellular Cations Defines a Kinetic Decision Point in the Transport Cycle of the Human Serotonin Transporter.
Hasenhuetl PS; Freissmuth M; Sandtner W
J Biol Chem; 2016 Dec; 291(50):25864-25876. PubMed ID: 27756841
[TBL] [Abstract][Full Text] [Related]
11. Sodium Binding Stabilizes the Outward-Open State of SERT by Limiting Bundle Domain Motions.
Szöllősi D; Stockner T
Cells; 2022 Jan; 11(2):. PubMed ID: 35053371
[TBL] [Abstract][Full Text] [Related]
12. Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter.
Combs S; Kaufmann K; Field JR; Blakely RD; Meiler J
ACS Chem Neurosci; 2011 Feb; 2(2):75-81. PubMed ID: 22778858
[TBL] [Abstract][Full Text] [Related]
13. A dualistic conformational response to substrate binding in the human serotonin transporter reveals a high affinity state for serotonin.
Bjerregaard H; Severinsen K; Said S; Wiborg O; Sinning S
J Biol Chem; 2015 Mar; 290(12):7747-55. PubMed ID: 25614630
[TBL] [Abstract][Full Text] [Related]
14. Homology modeling of the serotonin transporter: insights into the primary escitalopram-binding site.
Jørgensen AM; Tagmose L; Jørgensen AM; Topiol S; Sabio M; Gundertofte K; Bøgesø KP; Peters GH
ChemMedChem; 2007 Jun; 2(6):815-26. PubMed ID: 17405130
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.
Plenge P; Abramyan AM; Sørensen G; Mørk A; Weikop P; Gether U; Bang-Andersen B; Shi L; Loland CJ
Nat Commun; 2020 Mar; 11(1):1491. PubMed ID: 32198394
[TBL] [Abstract][Full Text] [Related]
16. Structure/function relationships in serotonin transporter: new insights from the structure of a bacterial transporter.
Rudnick G
Handb Exp Pharmacol; 2006; (175):59-73. PubMed ID: 16722230
[TBL] [Abstract][Full Text] [Related]
17. Putative drug binding conformations of monoamine transporters.
Ravna AW; Sylte I; Kristiansen K; Dahl SG
Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
[TBL] [Abstract][Full Text] [Related]
18. Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter.
Plenge P; Shi L; Beuming T; Te J; Newman AH; Weinstein H; Gether U; Loland CJ
J Biol Chem; 2012 Nov; 287(47):39316-26. PubMed ID: 23007398
[TBL] [Abstract][Full Text] [Related]
19. Substrate-induced conformational dynamics of the dopamine transporter.
Nielsen AK; Möller IR; Wang Y; Rasmussen SGF; Lindorff-Larsen K; Rand KD; Loland CJ
Nat Commun; 2019 Jun; 10(1):2714. PubMed ID: 31221956
[TBL] [Abstract][Full Text] [Related]
20. Substrate and inhibitor binding to the serotonin transporter: Insights from computational, crystallographic, and functional studies.
Zeppelin T; Ladefoged LK; Sinning S; Schiøtt B
Neuropharmacology; 2019 Dec; 161():107548. PubMed ID: 30807752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
